Medicines
SmPC of 10/08/2021
MAGNESIUM OLIGOSOL, oral solution in ampoule
Composition
For one ampoule of 2 ml:
Magnesium gluconate: 1,781 mg
(Corresponding quantity of magnesium: 0,1044 mg)
Excipient with known effect: glucose (100 mg in one ampoule of 2 ml).
Glucose monohydrate and purified water.
Indications
Used as a terrain modifier, in particular during states of neurovegetative dystonia and states grouped under the term spasmophilia.
Dosage and administration
Dosage
FOR ADULTS ONLY.
1 to 3 ampoules per day.
The ampoules are to be taken:
- preferably in the morning on an empty stomach,
- possibly 15 minutes before a meal or in the evening at bedtime.
Method of administration
Oral use
Sublingual administration is recommended: hold the contents of the ampoule under the tongue for 1 to 2 minutes before swallowing.
Contraindications
Hypersensitivity to the active substance or to any of the excipients listed in section Composition.
Warnings and precautions
This medicine contains glucose. Patients with glucose-galactose malabsorption syndrome (a rare hereditary disease) must not take this medicine.
Treatment with this trace mineral element does not replace any specific treatment that may be needed.
Interactions
The data available to date do not suggest the existence of clinically significant interactions.
Fertility, pregnancy and breastfeeding
No adverse effects are expected with these doses of magnesium during pregnancy and breastfeeding.
Driving and using machines
MAGNESIUM OLIGOSOL, oral solution in ampoule has no effect on the ability to drive vehicles or use machines.
Adverse effects
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system: National Agency for the Safety of Medicines and Health Products (ANSM) and the network of Regional Pharmacovigilance Centres - Website: https://signalement.social-sante.gouv.fr.
Prescription, supply and reimbursement
| Marketing authorisation (AMM) |
|
GRANIONS EA-PHARMA Laboratory
Le Parador II
5, allée Crovetto-Frères. 98000 Monaco
Tel: 00 377 92 05 76 30
Source: VIDAL · Updated on 11/11/2026. This information does not replace advice from a healthcare professional.
